FACTANKER · measured, cited, anchored official records connected

SEC EDGAR CompanyFacts fact · point in time

enGene Therapeutics Inc.: common_shares_outstanding

One fact, its scope and the complete path back to the official record.

Period: as of 2026-02-17Status: currentProvenance attached

Cite: FACTANKER, https://factanker.com/fact/943d868a-ff00-4fa3-b2b3-8ec5fe2a3c7e

Reported value

66989466{"unit": "shares", "value": 66989466, "concept": "dei:EntityCommonStockSharesOutstanding"}
Entity
enGene Therapeutics Inc.
Metric
common_shares_outstanding
Period
as of 2026-02-17
Status
current
Source
SEC EDGAR CompanyFacts

Provenance

Official reference0001193125-26-059409 · Open the official SEC filing →
Source licenseUS-PD-17USC105
Retrieved2026-08-19T19:02:21.808587+02:00
Raw response SHA-256f7bde1a401b286c74a2fd824ee1df541…
Official-identifier pathhttps://factanker.com/fact/sec/cik-0001980845/common-shares-outstanding/2026-02-17 (CIK, metric, reporting date)
History
  • no predecessors — first report

Why this page exists

The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.